Free Trial

Medtronic (MDT) Stock Forecast & Price Target

Medtronic logo
$80.70 -0.21 (-0.25%)
Closing price 03:59 PM Eastern
Extended Trading
$80.85 +0.15 (+0.18%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Medtronic - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
8
Buy
8

Based on 17 Wall Street analysts who have issued ratings for Medtronic in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 1 has given a sell rating, 8 have given a hold rating, 7 have given a buy rating, and 1 has given a strong buy rating for MDT.

Consensus Price Target

$96.07
19.04% Upside
According to the 17 analysts' twelve-month price targets for Medtronic, the average price target is $96.07. The highest price target for MDT is $109.00, while the lowest price target for MDT is $83.00. The average price target represents a forecasted upside of 19.04% from the current price of $80.70.
Get the Latest News and Ratings for MDT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Medtronic and its competitors.

Sign Up

MDT Analyst Ratings Over Time

TypeCurrent Forecast
5/23/24 to 5/23/25
1 Month Ago
4/23/24 to 4/23/25
3 Months Ago
2/23/24 to 2/22/25
1 Year Ago
5/24/23 to 5/23/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
6 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
Hold
8 Hold rating(s)
8 Hold rating(s)
9 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$96.07$96.14$95.00$94.91
Forecasted Upside19.04% Upside14.80% Upside5.62% Upside16.62% Upside
Consensus Rating
Hold
Hold
Hold
Hold

MDT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MDT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Medtronic Stock vs. The Competition

TypeMedtronicMedical CompaniesS&P 500
Consensus Rating Score
2.47
2.81
2.54
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside18.70% Upside5,056.10% Upside15.96% Upside
News Sentiment Rating
Positive News

See Recent MDT News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/22/2025Mizuho
3 of 5 stars
Anthony Petrone
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$100.00 ➝ $98.00+19.99%
5/22/2025Royal Bank of Canada
3 of 5 stars
Shagun Singh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$105.00 ➝ $101.00+24.10%
5/22/2025Robert W. Baird
2 of 5 stars
David Rescott
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$94.00 ➝ $92.00+12.71%
5/19/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Mike Matson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
4/11/2025Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Richard Newitter
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$93.00 ➝ $90.00+10.25%
3/4/2025Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Joanne Wuensch
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$92.00 ➝ $107.00+13.59%
2/19/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Danielle Antalffy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$85.00 ➝ $95.00+10.40%
11/26/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$105.00 ➝ $109.00+27.11%
11/20/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$96.00 ➝ $97.00+15.68%
11/20/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$106.00 ➝ $98.00+13.95%
11/15/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$99.00 ➝ $96.00+9.84%
10/1/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$100.00 ➝ $104.00+16.16%
8/23/2024Daiwa America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Department
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/21/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$85.00 ➝ $90.00+4.41%
8/21/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$85.00 ➝ $87.00+1.90%
8/21/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$92.00 ➝ $94.00+10.10%
5/30/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell$83.00+1.84%
11/22/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$104.00 ➝ $98.00+24.68%
6/30/202322nd Century Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingInitiates
6/30/2023CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$106.00+22.16%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:49 PM ET.


Should I Buy Medtronic Stock? MDT Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, May 21, 2025. Please send any questions or comments about these Medtronic pros and cons to contact@marketbeat.com.

Medtronic
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Medtronic plc:

  • The current stock price is around $86, which is near its fifty-two week high, indicating strong market performance and investor confidence.
  • Medtronic plc reported a quarterly earnings per share (EPS) of $1.39, exceeding analysts' expectations, which reflects the company's robust financial health and operational efficiency.
  • The company has a solid dividend yield of approximately 3.24%, providing a steady income stream for investors, which is particularly attractive in a low-interest-rate environment.
  • Analysts have a consensus rating of "Hold" with several upgrades, suggesting that there is potential for price appreciation and stability in the stock.
  • Medtronic plc has a return on equity of 14.07%, indicating effective management and profitability, which can lead to increased shareholder value over time.

Medtronic
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Medtronic plc for these reasons:

  • The company has a relatively high price-to-earnings (P/E) ratio of 26.27, which may suggest that the stock is overvalued compared to its earnings, potentially limiting future price growth.
  • Medtronic plc's revenue for the last quarter was slightly below analyst estimates, which could indicate challenges in meeting growth expectations.
  • The dividend payout ratio is quite high at 85.11%, which may raise concerns about the sustainability of future dividends if earnings do not grow as expected.
  • Market volatility is reflected in the stock's beta of 0.81, suggesting that while it is less volatile than the market, any downturns could still impact the stock significantly.
  • With a significant number of analysts rating the stock as a "Hold," there may be limited upside potential in the near term, indicating a lack of strong bullish sentiment.

MDT Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Medtronic is $96.07, with a high forecast of $109.00 and a low forecast of $83.00.

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There is currently 1 sell rating, 8 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.

According to analysts, Medtronic's stock has a predicted upside of 19.04% based on their 12-month stock forecasts.

Over the previous 90 days, Medtronic's stock had 1 upgrade by analysts.

Medtronic has been rated by research analysts at Citigroup, Mizuho, Needham & Company LLC, Robert W. Baird, Royal Bank of Canada, and Truist Financial in the past 90 days.

Analysts like Medtronic less than other "medical" companies. The consensus rating for Medtronic is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MDT compares to other companies.


This page (NYSE:MDT) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners